4-AcO-DiPT
4-AcO-DiPT (4-acetoxy-N,N-diisopropyltryptamine) is a synthetic tryptamine sold as a research chemical. It is the acetate ester of 4-HO-DiPT and is generally assumed to act as a prodrug for it, analogous to how 4-AcO-DMT relates to psilocin. Human data are limited to anecdotal reports with no controlled studies.
01 Overview
4-AcO-DiPT (sometimes called ipracetin) is the O-acetylated form of 4-HO-DiPT. By analogy with other 4-acetoxy tryptamines it is presumed to be deacetylated in the body to the active 4-hydroxy compound, though this metabolism has not been formally confirmed in humans.
There is no clinical or rigorous pharmacokinetic literature. Reported effects mirror 4-HO-DiPT, with a short-to-moderate duration. It circulates in the grey-market research chemical trade.
02 Mechanism
Presumed prodrug for 4-HO-DiPT, a serotonin 5-HT2A receptor agonist; deacetylation to the active phenol is assumed but not confirmed in humans.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Light | 8–15 mg | Oral | Anecdotal; no validated dosing. |
| Common | 15–30 mg | Oral | Anecdotal range from user reports. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Psychedelic perceptual alterationVisual and mood effects resembling 4-HO-DiPT, per user reports. | Dose-dependent | Anecdotal | |
| EuphoriaSome users describe mood elevation; unverified. | Variable | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Gastrointestinal upsetNausea reported by some users. | Mild | Unknown | Anecdotal | |
| AnxietyAnxiety and unease reported at higher doses. | Moderate | Unknown | Anecdotal |